Impact of Robotic Surgery on Systemic Immune-inflammation Index

Başakşehir Çam & Sakura City Hospital

Status: Completed

Conditions: Gastric Cancer

Treatments: Procedure: robotic surgery

Study type: Observational

Funder types: Other

Identifiers

NCT06811753

BasaksehirCamveSakura 2024-52

Details and patient eligibility

About

Robotic surgery has been gaining attention because of the physical and metabolic morbidity of the conventional open technique.The systemic immune-inflammation index(SII) has emerged as a recent and more reliable biomarker.In our single-center retrospective cohort study, the investigators investigate SII in robotic gastrectomy in order to show the advantageous effect on immune system which the investigators think as the first study in the literature.

Full description

Patients who underwent robotic gastrectomy between January 2021 and September 2024 were included in the study. The primary outcome was to ascertain the beneficial effects of robotic surgery in gastric cancer patients in terms of immune response. The secondary outcome was to examine the reliability of SII as a serum biomarker in comparison to previous studies on the diagnosis and postoperative follow-up of gastric cancer.

Enrollment: 300 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

gastric cancer patients treated with surgery

Exclusion criteria

patients with haematologic malignancy, immune system disorder, antiplatelet drug usage, operations including splenectomy

Trial design

300 participants in 3 patient groups

Group 1

Description:

robotic surgery

Treatment:

Procedure: robotic surgery

Group 2

Description:

laparoscopic surgery

Group 3

Description:

open surgery